Summary: Adding the Nav1.1 protein boosted the activity of interneurons and helped restore brain function in mouse models of Alzheimer’s disease, researchers report.
Source: Gladstone Institute.
Like a great orchestra, your brain relies on the perfect coordination of many elements to function properly. And if one of those elements is out of sync, it affects the entire ensemble. In Alzheimer’s disease, for instance, damage to specific neurons can alter brainwave rhythms and cause a loss of cognitive functions.
One type of neuron, called inhibitory interneuron, is particularly important for managing brain rhythms. It’s also the research focus of a laboratory led by Jorge Palop, PhD, assistant investigator at the Gladstone Institutes. In a study published in Neuron, Palop and his collaborators uncovered the therapeutic benefits of genetically improving these interneurons and transplanting them into the brain of a mouse model of Alzheimer’s disease.
Interneurons control complex networks between neurons, allowing them to send signals to one another in a harmonized way. You can think of inhibitory interneurons as orchestra conductors. They create rhythms in the brain to instruct the players–excitatory neurons–when to play and when to stop. An imbalance between these two types of neurons creates disharmony and is seen in multiple neurological and psychiatric disorders, including Alzheimer’s disease, epilepsy, schizophrenia, and autism.
A Brain without a Conductor
Palop’s previous studies showed that, in mouse models of Alzheimer’s, the inhibitory interneurons do not work properly. So, the rhythms that organize the excitatory cells are disturbed and fail to function harmoniously, causing an imbalance in brain networks. This, in turn, affects memory formation and can lead to epileptic activity, which is often observed in patients with Alzheimer’s disease.
His team found a way to reengineer inhibitory interneurons to improve their function. They showed that these enhanced interneurons, when transplanted into the abnormal brain of Alzheimer mice, can properly control the activity of excitatory cells and restore brain rhythms.
“We took advantage of the fact that transplanted interneurons can integrate remarkably well into new brain tissues, and that each interneuron can control thousands of excitatory neurons,” said Palop, who is also an assistant professor of neurology at the University of California, San Francisco. “These properties make interneurons a promising therapeutic target for cognitive disorders associated with brain rhythm abnormalities and epileptic activity.”
First, the scientists had to overcome a significant challenge. When they transplanted regular interneurons, they saw no beneficial effects, presumably because Alzheimer’s disease creates a toxic environment in the brain.
The researchers then genetically boosted the activity of inhibitory interneurons by adding a protein called Nav1.1. They discovered that the interneurons with enhanced function were able to overcome the toxic disease environment and restore brain function.
“These optimized neurons are like master conductors,” said Palop. “Even with a declining orchestra, they can restore the rhythms and harmony needed for cognitive functions.”
Conductors Engineered for Alzheimer’s Disease
The findings could eventually lead to the development of new treatment options for patients with Alzheimer’s disease.
“Besides the applications this cell engineering and transplantation approach may find in regenerative medicine, our findings support the broader concept that enhancing the function of interneurons can counteract key aspects of Alzheimer’s disease,” said Lennart Mucke, MD, director of the Gladstone Institute of Neurological Disease.
In addition to examining if the cell therapy could be translated from mice to humans, Palop and his team are working to identify potential drugs as an alternative way to enhance the function of inhibitory interneurons.
“Advancing our understanding of Alzheimer’s disease and identifying potential new treatment strategies are critical to addressing the escalating global health crisis,” said Elizabeth Edgerly, PhD, executive director of the Alzheimer’s Association, Northern California and Northern Nevada chapter. “We were proud to support Dr. Palop’s research and vision with an Investigator Initiated Research Grant award.” The Alzheimer’s Association, which funded part of the study, is the world’s largest nonprofit funder of Alzheimer’s research.
The study’s first equal contribution authors are Magdalena Martinez-Losa, Tara Tracy, and Keran Ma. Other contributors include Laure Verret, Alexandra Clemente-Perez, Abdullah Khan, Inma Cobos, Kaitlyn Ho, Li Gan, Lennart Mucke, Manuel Alvarez-Dolado, and Jorge Palop.
Funding: The research at Gladstone was funded by the National Institutes of Health, the Alzheimer’s Association, and the S.D. Bechtel, Jr. Foundation.
Source: Julie Langelier – Gladstone Institute
Publisher: Organized by NeuroscienceNews.com.
Image Source: NeuroscienceNews.com image is in the public domain.
Original Research: Open access research in Neuron.
[cbtabs][cbtab title=”MLA”]Gladstone Institute “Cell Therapy Could Improve Brain Function in Alzheimer’s.” NeuroscienceNews. NeuroscienceNews, 17 March 2018.
<https://neurosciencenews.com/cell-transplant-alzheimers-8655/>.[/cbtab][cbtab title=”APA”]Gladstone Institute (2018, March 17). Cell Therapy Could Improve Brain Function in Alzheimer’s. NeuroscienceNews. Retrieved March 17, 2018 from https://neurosciencenews.com/cell-transplant-alzheimers-8655/[/cbtab][cbtab title=”Chicago”]Gladstone Institute “Cell Therapy Could Improve Brain Function in Alzheimer’s.” https://neurosciencenews.com/cell-transplant-alzheimers-8655/ (accessed March 17, 2018).[/cbtab][/cbtabs]
Nav1.1-Overexpressing Interneuron Transplants Restore Brain Rhythms and Cognition in a Mouse Model of Alzheimer’s Disease
•Nav1.1-enhanced interneuron transplants reduce deficits in Alzheimer model
•Nav1.1-deficient interneuron transplants cause behavioral deficits in wild-type mice
•Nav1.1 elevation accelerates action potential kinetics in transplanted interneurons
•Molecular optimization of cell transplants is required for therapeutic benefits
Inhibitory interneurons regulate the oscillatory rhythms and network synchrony that are required for cognitive functions and disrupted in Alzheimer’s disease (AD). Network dysrhythmias in AD and multiple neuropsychiatric disorders are associated with hypofunction of Nav1.1, a voltage-gated sodium channel subunit predominantly expressed in interneurons. We show that Nav1.1-overexpressing, but not wild-type, interneuron transplants derived from the embryonic medial ganglionic eminence (MGE) enhance behavior-dependent gamma oscillatory activity, reduce network hypersynchrony, and improve cognitive functions in human amyloid precursor protein (hAPP)-transgenic mice, which simulate key aspects of AD. Increased Nav1.1 levels accelerated action potential kinetics of transplanted fast-spiking and non-fast-spiking interneurons. Nav1.1-deficient interneuron transplants were sufficient to cause behavioral abnormalities in wild-type mice. We conclude that the efficacy of interneuron transplantation and the function of transplanted cells in an AD-relevant context depend on their Nav1.1 levels. Disease-specific molecular optimization of cell transplants may be required to ensure therapeutic benefits in different conditions.